<DOC>
	<DOCNO>NCT00632385</DOCNO>
	<brief_summary>To assess efficacy safety eletriptan migraine headache subject satisfy rizatriptan therapy</brief_summary>
	<brief_title>Efficacy Safety Eletriptan Treatment Migraine Patients Not Satisfied With Rizatriptan Therapy</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Eletriptan</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Diagnosis migraine headache accord International Headache Society criterion migraine headache least 1 year Eletriptan naive Previously treat rizatriptan fail achieve satisfactory response within past 12 month Nonmigraine headaches average 6 day per month le 24 hour freedom headache migraine attack Migraine attack atypical chronic daily headaches A history migraine prolong aura , familial hemiplegic migraine , basilar migraine , migrainous infarction , migraine aura without headache , migraine acute onset aura</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>